8,864 reports of this reaction
2.1% of all QUETIAPINE reports
#5 most reported adverse reaction
FATIGUE is the #5 most commonly reported adverse reaction for QUETIAPINE, manufactured by H2-Pharma, LLC. There are 8,864 FDA adverse event reports linking QUETIAPINE to FATIGUE. This represents approximately 2.1% of all 427,224 adverse event reports for this drug.
QUETIAPINE has an overall safety score of 85 out of 100. Patients taking QUETIAPINE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for QUETIAPINE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for QUETIAPINE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 8,864 FDA reports for QUETIAPINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.1% of all adverse event reports for QUETIAPINE, making it a notable side effect.
If you experience fatigue while taking QUETIAPINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.